Royalty Pharma plc (RPRX) 

NASDAQ$36.07
Market Cap
$15.59B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
738 of 840
Rank in Industry
421 of 479

RPRX Insider Trading Activity

RPRX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$1,213,749
1
100

Related Transactions

Norden Gregorydirector
0
$0
1
$1.21M
$-1.21M

About Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies â€¦

Insider Activity of Royalty Pharma plc

Over the last 12 months, insiders at Royalty Pharma plc have bought $0 and sold $1.21M worth of Royalty Pharma plc stock.

On average, over the past 5 years, insiders at Royalty Pharma plc have bought $7.24M and sold $168.05M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 130,000 shares for transaction amount of $3.84M was made by Legorreta Pablo G. (CEO, Chairman of the Board) on 2023‑06‑28.

List of Insider Buy and Sell Transactions, Royalty Pharma plc

2025-08-11SaleNorden Gregorydirector
33,500
0.008%
$36.23
$1.21M
-0.24%
2024-01-04SaleRIGGS RORY Bdirector
35,702
0.0083%
$27.55
$983,504
+1.69%
2024-01-03SaleRIGGS RORY Bdirector
199,098
0.0467%
$27.79
$5.53M
+1.83%
2024-01-02SaleRIGGS RORY Bdirector
235,200
0.0566%
$28.52
$6.71M
-0.09%
2023-12-29SaleAvara Management Ltd10 percent owner
65,803
0.0156%
$28.04
$1.85M
+0.67%
2023-12-28SaleAvara Management Ltd10 percent owner
209,863
0.05%
$28.20
$5.92M
+1.12%
2023-12-27SaleAvara Management Ltd10 percent owner
41,729
0.0099%
$28.01
$1.17M
+0.93%
2023-12-15SaleAvara Management Ltd10 percent owner
10,229
0.0024%
$28.01
$286,499
+3.32%
2023-12-14SaleAvara Management Ltd10 percent owner
364,441
0.0889%
$28.91
$10.53M
-1.24%
2023-12-13SaleAvara Management Ltd10 percent owner
307,935
0.0753%
$28.95
$8.92M
-3.25%
2023-08-10SaleCoyne Terrance P.EVP & CFO
37,500
0.0097%
$30.75
$1.15M
-6.45%
2023-08-09SaleCoyne Terrance P.EVP & CFO
37,500
0.0097%
$30.72
$1.15M
-6.26%
2023-07-13SaleCoyne Terrance P.EVP & CFO
37,500
0.0098%
$30.93
$1.16M
-6.49%
2023-07-12SaleCoyne Terrance P.EVP & CFO
37,500
0.0098%
$31.07
$1.17M
-8.20%
2023-06-28PurchaseLegorreta Pablo G.CEO, Chairman of the Board
130,000
0.0324%
$29.51
$3.84M
-2.63%
2023-06-13PurchaseLegorreta Pablo G.CEO, Chairman of the Board
45,000
0.0125%
$32.78
$1.47M
-10.39%
2023-06-12PurchaseLegorreta Pablo G.CEO, Chairman of the Board
45,000
0.0125%
$33.00
$1.48M
-11.51%
2023-06-06SaleLloyd George W.EVP, Investments & CLO
79,099
0.0226%
$33.82
$2.67M
-14.02%
2023-06-05SaleLloyd George W.EVP, Investments & CLO
19,215
0.0054%
$33.54
$644,446
-12.63%
2023-06-02SaleLloyd George W.EVP, Investments & CLO
93,907
0.0267%
$33.64
$3.16M
-12.78%
Total: 236
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
ADAGE CAPITAL PARTNERS GP, L.L.C.10 percent owner
38714280
8.9556%
$1.4B12
<0.0001%
Giuliani Mario Germanodirector
7795072
1.8032%
$281.17M110
<0.0001%
Lappe Mark
4292136
0.9929%
$154.82M100
PERCEPTIVE ADVISORS LLC10 percent owner
2862560
0.6622%
$103.25M143
Efficacy Capital, Ltd.10 percent owner
2552233
0.5904%
$92.06M3620
FORD WILLIAM Edirector
1500000
0.347%
$54.1M10
<0.0001%
Coyne Terrance P.EVP & CFO
790000
0.1827%
$28.5M19
<0.0001%
Legorreta Pablo G.CEO, Chairman of the Board
600000
0.1388%
$21.64M70
<0.0001%
Fernandez Henry Adirector
58200
0.0135%
$2.1M20
<0.0001%
Hite ChristopherEVP & Vice Chairman
30541
0.0071%
$1.1M11
<0.0001%
Lloyd George W.EVP, Investments & CLO
30000
0.0069%
$1.08M134
<0.0001%
RIGGS RORY Bdirector
20099
0.0046%
$724,970.93128
<0.0001%
REED JOHN Cdirector
3846
0.0009%
$138,725.2210
Masterson Nola Edirector
0
0%
$061
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$961,890,236
276
22.46%
$16.92B
$211,610,344
91
38.45%
$9.65B
$2,765,836
72
20.00%
$11.09B
$108,876,545
67
72.81%
$8.76B
$2,449,191,716
58
16.50%
$59.73B

RPRX Institutional Investors: Active Positions

Increased Positions258+51.39%54M+16.6%
Decreased Positions225-44.82%34M-10.37%
New Positions78New25MNew
Sold Out Positions68Sold Out5MSold Out
Total Postitions535+6.57%344M+6.23%

RPRX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Morgan Stanley$1.68M10.79%46.6M+6M+13.59%2025-06-30
Fmr Llc$1.45M9.34%40.36M+953,728+2.42%2025-06-30
Vanguard Group Inc$1.31M8.42%36.38M-299,770-0.82%2025-06-30
Blackrock, Inc.$914,930.005.89%25.43M+872,994+3.56%2025-06-30
Capital International Investors$787,265.005.07%21.88M+22MNew2025-06-30
Baillie Gifford & Co$648,376.004.17%18.02M+5M+34.46%2025-06-30
Swedbank Ab$437,426.002.81%12.16M00%2025-06-30
State Street Corp$366,814.002.36%10.19M+678,810+7.13%2025-06-30
Geode Capital Management, Llc$294,191.001.89%8.18M+177,036+2.21%2025-06-30
Caledonia (Private) Investments Pty Ltd$231,881.001.49%6.44M+1M+26.01%2025-06-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.